Home›Stocks›REGN

REGN — structural market context

Regeneron Pharmaceuticals, Inc

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

REGN short interest & days to cover

SHARES SHORT

3.4M

% OF FLOAT

—

DAYS TO COVER

3.9

CHANGE VS PRIOR

-3.3%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-07-31 (40d ago)

REGN fails-to-deliver (FTD)

Settlement date	Failed shares	Price
2026-08-14 · 26d	60	$805.97
2026-08-10 · 30d	1K	$784.36
2026-08-03 · 37d	132	$762.63

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

REGN insider buying and selling (Form 4)

Last 12 months, open-market only: 0 purchases · 3 sales

Insider	Type	Shares	Value	Filed
McCourt Marion · officer: EVP Commercial	Sell (S)	1K	$1.0M	2026-09-03
McCourt Marion · officer: EVP Commercial	Sell (S)	1K	$970K	2026-09-03
Guarini Kathryn · director	Sell (S)	400	$340K	2026-09-03

SEC Form 4 filings, open-market purchases and sales only (codes P and S); grants and option exercises excluded. Attributed public records.

REGN analyst ratings — with each firm's measured accuracy

Firm	Action	Rating	Firm 5d hit rate*	Published
RBC Capital	hold	Sector Perform	52.9% (n=34)	2026-09-01
Leerink Partners	price_target	—	n<30	2026-08-17
Bernstein	hold	Market Perform	n<30	2026-08-14
Bernstein	price_target	—	n<30	2026-08-14

*Rating actions from public feeds. Where shown, the firm's 5-day hit rate is our measured backtest (firms with >=30 graded calls); a historical hit rate describes past calls, it does not grade this one.

Frequently asked questions

Are insiders buying REGN?

In the last 12 months of SEC Form 4 filings, REGN recorded 0 open-market insider purchases and 3 open-market sales (codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.

What do analysts say about REGN?

The most recent action: RBC Capital hold to Sector Perform on 2026-09-01. In our backtest, RBC Capital's 5-day hit rate across 34 graded calls is 52.9%. We show each firm's measured record next to its ratings; a historical hit rate describes past calls and does not grade this one.

Is this page telling me to buy or sell REGN?

No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.

All covered stocks Short Interest & FTD tracker Insider Buying tracker The platform

More tickers starting with R

RARE · Ultragenyx Pharmaceutical Inc.RCG · RENN Fund Inc.RELY · Remitly Global, Inc. Common St RGTI · Rigetti Computing, Inc. Common RKLB · Rocket Lab Corporation Common RMD · ResMed Inc.All R →

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.